Global Inhaler Corticosteroid Device Market- By Steroid Types
Global Inhaler Corticosteroid Device Market- By Application
Global Inhaler Corticosteroid Device Market- By End-User
Global Inhaler Corticosteroid Device Market- By Region
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Inhaler Corticosteroid Device Market Snapshot
Chapter 4. Global Inhaler Corticosteroid Device Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Steroid Types Estimates & Trend Analysis
5.1. by Steroid Types & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Steroid Types:
5.2.1. Beclomethasone Dipropionate
5.2.2. Budesonide
5.2.3. Fluticasone Inhaler Powder
5.2.4. Mometasone
Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis
6.1. by Application & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:
6.2.1. Asthma
6.2.2. COPD (Chronic Obstructive Pulmonary Disease)
6.2.3. Others
Chapter 7. Market Segmentation 3: by End-user Estimates & Trend Analysis
7.1. by End-user & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-user:
7.2.1. Hospitals and Clinics
7.2.2. Academic and Research Institutes
Chapter 8. Inhaler Corticosteroid Device Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by Steroid Types, 2019-2031
8.1.2. North America Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
8.1.3. North America Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2019-2031
8.1.4. North America Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.2. Europe
8.2.1. Europe Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by Steroid Types, 2019-2031
8.2.2. Europe Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
8.2.3. Europe Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2019-2031
8.2.4. Europe Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by Steroid Types, 2019-2031
8.3.2. Asia Pacific Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
8.3.3. Asia-Pacific Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2019-2031
8.3.4. Asia Pacific Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.4. Latin America
8.4.1. Latin America Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by Steroid Types, 2019-2031
8.4.2. Latin America Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
8.4.3. Latin America Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2019-2031
8.4.4. Latin America Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by Steroid Types, 2019-2031
8.5.2. Middle East & Africa Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
8.5.3. Middle East & Africa Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2019-2031
8.5.4. Middle East & Africa Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. -La Roche Ltd. (Switzerland)
9.2.3. Pfizer Inc.
9.2.4. GlaxoSmithKline plc
9.2.5. Novartis AG
9.2.6. Mylan N.V.
9.2.7. Teva Pharmaceutical Industries Ltd.
9.2.8. Sanofi
9.2.9. Boehringer Ingelheim International GmbH.
9.2.10. AstraZeneca
9.2.11. F. Hoffmann-La Roche Ltd.
9.2.12. Bristol-Myers Squibb Company
9.2.13. Amgen Inc.
9.2.14. Aurobindo Pharma
9.2.15. Eli Lilly and Company
9.2.16. Cipla Inc.
9.2.17. Sumitomo Corporation
9.2.18. Other Prominent Players
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.